14 Jun 2018

VEIN SPECIALISTS PODCAST WITH VTN’S OWN GARY PITTMAN

Gary Pittman from Vein Therapy News joins Vein Specialists today to discuss his background and experience with the vein industry. Vein Therapy News is teaming with the latest news on products, services, and breakthroughs in the vein treatment industry. We discuss technology and how it is changing the face of

0
Manamed PlasmaFlow photo
02 Nov 2017

FDA approves DVT prevention device

California-based ManaMed has launched the U.S. Food and Drug Administration (FDA) approved deep vein thrombosis (DVT) prevention device PlasmaFlow in the United States. The portable, tubeless and digital PlasmaFlow, which comes with multiple pressure functions, helps to prevent the onset of DVT in patients by revitalizing blood flow in the

0
Reva scaffolding
02 Nov 2017

Reva scaffolding study yields good results

As some companies have worked to improve drug-eluting stents by making them bioresorbable, some voices in the coronary intervention space have expressed concern over the rates of late stent thrombosis and repeat percutaneous coronary intervention seen with the devices. In a study published in a recent issue of JACC: Cardiovascular

0
Medtronic Concerto
02 Nov 2017

Medtronic Concerto 3D Detachable Coil unveiled for vein embolization

Medtronic has unveiled its new Concerto 3D Detachable Coil System that is intended to be used for embolizations in the peripheral arteries and veins. The device was unveiled at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting in Copenhagen, Denmark in September. The device, which is now available to physicians

0
: http://www.veintherapynews.com/ex-employee-char…r-financial-gain/ ‎
02 Nov 2017

Boston Scientific to distribute Veniti VICI Venous Stent

Veniti Inc., a research company in the advancement of treatment for deep venous disease, has announced that Boston Scientific will distribute its VICI Venous Stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries involved were not disclosed. Physicians treat the obstructive component

0
access vascular hydropicc catheter illustration
02 Nov 2017

Access Vascular HydroPICC cath raises $4M

Medical device developer Access Vascular has raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk. The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the risk of thrombosis. Financing will support the submission of an

0
: http://www.veintherapynews.com/ex-employee-char…r-financial-gain/ ‎
02 Nov 2017

Thrombectomy device market to reach $1.45B value by 2022

The global thrombectomy devices market is expected to reach a value of $1.45 billion by 2022, growing at a CAGR of 6.7 percent during the forecast period, according to a new Research and Markets report, “Thrombectomy Devices Market – Global Forecasts to 2022.” The growing target patient population, ongoing technological

0
02 Nov 2017

Americas will benefit most with IVC filter market growth

Market research analysts at Technavio predict that the global inferior vena cava (IVC) filter market will grow steadily during the next four years and post a CAGR of more than 11 percent by 2021. This market research analysis identifies the preference for minimally invasive procedures with improved medical imaging as

0
: http://www.veintherapynews.com/ex-employee-char…r-financial-gain/ ‎
02 Nov 2017

ElastiMed raises $1M in second funding round

In its second round of funding in October, Israeli medical startup ElastiMed has raised $1 million from a strategic investor, existing investors — The Trendlines Group and Pix Vine Capital — new private investors, and the Israeli Innovation Authority. ElastiMed, which was founded in 2015, has developed a wearable medical device

0
02 Nov 2017

NH takes med license from elderly doc not using computer

An 85-year-old doctor went to court Nov. 3 to keep her medical license, which is at risk because she doesn’t use computers and therefore can’t comply with the use of the state’s prescription drug monitoring program (PDMP). Anna Konopka, MD and a general practitioner in New London, N.H., was told to stop

0